How Pharmaceutical Companies Can Take Advantage of the EHR Revolution

Electronic Health Reporter

The article How Pharmaceutical Companies Can Take Advantage of the EHR Revolution appeared first on electronichealthreporter.com. Editorial electronic health records formularies are standardized PharmaceuticalThis content is copyrighted strictly for Electronic Health Reporter.

From Pharmaceuticals to Medical Devices: What to Watch in China's Healthcare Sector

Lloyd Price

In the latest episode of our podcast, Exchanges at Goldman Sachs, Stephanie Hui, head of Goldman Sachs' Merchant Banking Division in Asia-Pacific ex-Japan, explains how these dynamics are creating key investment opportunities in the pharmaceuticals, medical equipment and medical services markets. "People

Costs, Consumerism, Cyber and Care, Everywhere – The 2019 Health Populi TrendCast

Health Populi

Today is Boxing Day and St. Stephens Day for people who celebrate Christmas, so I share this post as a holiday gift with well-wishes for you and those you love.

Harnessing Innovation to Serve and Create Value for Patients

Electronic Health Reporter

By Georgia Mitsi, PhD, MBA, senior director and head of digital healthcare initiatives, Sunovion Pharmaceuticals Inc. Editorial Georgia Mitsi improving patient care Sunovion PharmaceuticalsThis content is copyrighted strictly for Electronic Health Reporter.

AHIP18: How Intermountain plans to fight pharmaceutical monopolies as a generic drugmaker

FierceHealthIT

After watching Martin Shkreli raise the price of a drug by more than 550% in 2015, Intermountain's Dan Liljenquist had the same thought as the rest of America: Is this really happening? So the system decided to create a nonprofit generic drug company that Liljenquist calls a “first-of-its-kind societal asset

Employers Take on Health Activism, Embracing Behavioral Health, Virtual Care, AI, and Transparency

Health Populi

One of the most concerning rising cost components in medical trend come from the pharmaceutical supply chain. The vast majority of employers do not believe the current rebate-based system works to reduce pharmaceutical costs, and most welcoming an alternative to rebates. More U.S.

Health Care for a Typical Working Family of Four in America Will Cost $28,166 in 2018

Health Populi

What could $28,166 buy you in 2018? A new car? A year of your child’s college education? A plot of land for your retirement home? Or a year of healthcare for a family of four?

Healthcare’s Profits Will Be Dramatically Redistributed as Care Shifts to Consumers: Accenture

Health Populi

All sectors who are stakeholders in the healthcare ecosystem aren’t created equal, Accenture explains in their report, Healthcare’s future winners and losers.

Consumers Changing the Channel on Where They Shop for Health

Health Populi

Consumers who have long purchased over-the-counter medicines, anti-dandruff shampoo, whitening toothpaste, and cosmetics-with-benefits at food, drug and mass merchant retailers are switching to other places to shop for health, new data from AT Kearney and GMDC have found.

Healthcare Policies We Can Agree On: Pre-Existing Conditions, Drug Prices, and PillPack – the June 2018 KFF Health Tracking Poll

Health Populi

EpiPen pricing mainstreamed the issue of pharmaceutical costs as a democratized (small “d”) issue in 2016, when Mylan grew the cost of a two-pack to about $600. There are countless chasms in the U.S. this moment in social, political, and economic perspectives.

How to Make Healthcare More Intelligent and Trustworthy: Accenture’s Digital Health Tech Vision 2018

Health Populi

“Do no harm” has been the professional and ethical mantra of physicians since the Hippocratic Oath was first uttered by medical students. The origins of that three-word objective probably came out of Hippocrates’ Corpus , which included a few additional words: “to do good or to do no harm.”.

Technology, Aging and Obesity Drive Healthcare Spending, BEA Finds

Health Populi

Financial health Health Consumers Health costs Health Economics Health policy Heart health Medicare Medicines Mental health Money and health Obesity Personal health finance Pharmaceutical Prescription drugs Prevention Public health Specialty drugs TransparencyThe U.S.

Doing Less Can Be Doing More for Healthcare – the Biggest Takeaway From ASCO 2018

Health Populi

Less can lead to more for so many things: eating smaller portions, lowering sugar consumption, and driving less in favor of walking or cycling come to mind. When it comes to healthcare utilization, doing less can also result in equal or even better outcomes.

How We Spend Versus What We Get: America’s Healthcare Spending Makes for Poor Health

Health Populi

had the highest pharmaceutical spending per capita of $1,443 versus $749 for the other nations, roughly double. The U.S. spent nearly twice as much as other wealthy countries on healthcare, mostly due to higher prices for both labor and products (especially prescription drugs).

CVS + Aetna: Inflection Point in US Healthcare, Merger Approved Update

Health Populi

During the hearing, Senator Patty Murray (D-WA) challenged Azar, “As a pharmaceutical executive, you raised drug prices year after year. CVS Health’s acquisition of Aetna was approved this week by U.S.

Self-Care is Healthcare for Everyday People

Health Populi

Patients are the new healthcare payors, and as such, taking on the role of health consumers. In fact, health and wellness consumers have existed since a person purchased the first toothpaste, aspirin, heating pad, and moisturizing cream at retail.

The US Covered Nearly 50% of Global Oncology Medicine Spending in 2017 – a market update from IQVIA

Health Populi

Cancer Financial health Financial wellness Global Health Health costs Health finance Health policy Medical innovation Medicines Money and health Pharmaceutical Pharmacy Prescription drugs Specialty drugs Sustainability

Koen Kas, the Gardener of Health Tech Delights

Health Populi

The future of healthcare is not about being sick, Prof. Dr. Koen Kas believes.

Rx 2018: A New Era of Specialty Drugs, Telehealth, Mobile Apps and Value, IQVIA Reports

Health Populi

The report pointed especially to hospital and pharmaceutical prices. President Trump made clear on the campaign trail and in his interview with TIME magazine as Person of the Year that pharmaceutical companies’ pricing needed to be reined in using government pressure.

Prescription Drugs: From Costs and Bad Reputation to Civica Rx and Amazon to the Rescue

Health Populi

consumers have long-ranked the pharmaceutical industry relatively low, but above car salespeople and the Federal government. The prices of medicines prescribed in outpatient settings rose, on average. 10.3% in 2018.

Americans’ Trust in the Healthcare System Low Compared to Rest-of-World’s Health Citizens

Health Populi

In the U.S., trust in the healthcare industry declined by 9 percentage points in just one year, declining from 62% of people trusting — that’s roughly two-thirds of Americans — down to 53% — closer to one-half of the population.

What the Pew Data on Americans’ Views on Technology Means for Healthcare

Health Populi

Most Americans say that pharmaceutical manufacturers, banks, advertisers, energy firms, and tech companies have too much power and influence in today’s American economy, according to Public Attitudes Toward Technology Companies , a research report from the Pew Research Center.

As Medical Cost Trend Remains Flat, Patients Face Growing Health Consumer Financial Stress

Health Populi

When it comes to healthcare costs, lines that decline over time are generally seen as good news. That’s how media outlets will cover the top-line of PwC’s report Medical cost trend: Behind the numbers 2019. However, there are other forces underneath the stable-looking 6.0%

The U.S. is a Nation in Pain – America’s Life Expectancy Fell Again in 2016

Health Populi

American saw the greatest number of deaths from suicide and alcohol- and drug-induced fatalities was recorded in 2016. That statistic of nearly 142,000 equates to deaths from stroke and exceed the number of deaths among Americans who died in all U.S.

Consumers Consider Cost When They Think About Medical Innovation

Health Populi

ACA Affordable Care Act Bio/life sciences Biotech Financial health Financial wellness Health Consumers Health costs Health disparities Health Economics Health finance Health law Health policy Health politics Health reform Medical innovation Medicines Money and health Pharmaceutical Trust

The Gap Between the Trump Administration’s Promise of Reducing Rx Costs for Consumers and What People Really Want

Health Populi

Smart Pharmaceuticals Index (NQSSPH) from May 11, 2018, the date when POTUS and Secretary Azar made their announcement.

Surprise, Surprise: Most Americans Have Faced a “Surprise” Medical Bill

Health Populi

Most Americans have been surprised by a medical bill, a NORC AmeriSpeak survey found. Who’s responsible? Nearly all Americans (86% net responsible) first blame health insurance companies, followed by hospitals (82%). Fewer U.S.

Pharma Spending Gone Bipolar: Generics At One End, Specialty Drugs on the Other

Health Populi

” These ratings cover over 2,100 pharmaceutical brands for which over 40,000 having submitted opinions. While the use of medicines continues to rise in the U.S., spending grew by only 0.6% in 2017 after accounting for discounts and rebates.

Healthcare Is Local: Channeling Tip O’Neill in the 2018 Midterm Election Results

Health Populi

Democrats have been committed to the concept of the government negotiating drug prices directly with pharmaceutical companies the way other developed countries do. As Tip O’Neill’s mantra goes, “All politics is local.” ” In the U.S.

At BIO 2018, digital technologies in pharma are gaining steam

Mobi Health News

Digital technologies are cementing their place across healthcare, and the pharmaceutical sector is no exception

150 top places to work in healthcare

Henry Kotula

[link]. Becker’s Healthcare is pleased to release the “150 Top Places to Work in Healthcare | 2018” list, which highlights hospitals, health systems and healthcare companies that promote diversity within the workforce, employee engagement and professional growth.

Pharmacies Continue to Earn Consumer-Love

Health Populi

Among industries that consumers frequent, one continues to delight people more than most: pharmacies. Power’s 2018 ratings on U.S. pharmacies finds that consumers do indeed still love their pharmacies after ten years of rating customer satisfaction with brick-and-mortar and mail order channels.

Pharma enthusiastic for digital medicine, but some roadblocks remain

Mobi Health News

During an afternoon roundtable session held yesterday at BIO 2018 in Boston, a panel of digital medicine and pharmaceutical representatives discussed the impact that these novel medicines has had, and could have, on drugmakers, regulators, and those prescribing the medications

China's online healthcare platform jianke.com enters into strategic collaboration with Pfizer

Mobi Health News

Jianke.com, China's online healthcare platform, yesterday announced during the Jianke Doctor Rebrand & 2018 Jianke Partners' Conference in Shanghai that they will be entering into a strategic partnership with US-based global pharmaceutical leader Pfizer

Janssen funds cancer study using Vital Connect, physIQ tech

Mobi Health News

Specifically, the study — which is funded by Johnson & Johnson subsidiary Janssen Pharmaceuticals — is looking to see how the technology can detect adverse events in cancer treatment early on.

Janssen funds cancer study using VitalConnect, physIQ tech

Mobi Health News

Specifically, the study — which is funded by Johnson & Johnson subsidiary Janssen Pharmaceuticals — is looking to see how the technology can detect adverse events in cancer treatment early on.

Proteus CMO talks regulation hurdles, future plans for digital pill

Mobi Health News

It’s still the early days, but the FDA’s approval of Proteus Digital Health and Otsuka Pharmaceuticals’ Abilify MyCite has changed the discussion of digital technology in healthcare

Consumerism coming to healthcare: Opportunities and obstacles

Mobi Health News

That's true across the range of hospitals, payers and pharmaceutical companies, according to new research by branding and marketing consultancy specialist Prophet

AI Can Improve Patient Outcomes, but will Pharma Get there Quickly Enough?

Lloyd Price

Machine learning is making the drug discovery process cheaper, faster, and more optimal for all involved AI is omnipresent and it’s no shock that it’s even crept its way into the highly regulated pharmaceutical industry, one that is usually risk averse and slow to adapt new technologies.

Healthcare Roundup—First cannabis-derived drug on market; Suit claims Anthem ignored Cigna merger risks

FierceHealthIT

GW Pharmaceuticals announces doctors can begin prescribing drug derived from cannabis; Anthem faces shareholder suit and more healthcare headlines from around the web